Stock listing

ANU Stock Price, News, Filings & Events — Xortx Therapeutics, Inc.

Selected listing: ANU · GETTEX · EUR · DE

The ANU:GETTEX listing represents Xortx Therapeutics, Inc., a biotechnology company focused on developing innovative therapies for kidney disease. The company is actively engaged in clinical research and has been making strides in advancing its product pipeline. Recent news includes updates on their ongoing studies and regulatory filings that highlight their commitment to addressing unmet medical needs in the renal health sector. Investors can find relevant events and market context that may impact the company's performance on this page.

ANU:GETTEXEURDEUpdated July 24, 2026
Xortx Therapeutics, Inc. logo
Ticker
ANU:GETTEX
Asset type
Stock
Market cap
$3.6M
Sector
Health Technology
Industry
Pharmaceuticals: Major
Exchange
GETTEX
Currency
EUR

Xortx Therapeutics, Inc. ANU:GETTEX stock context

The ANU:GETTEX listing represents Xortx Therapeutics, Inc., a biotechnology company focused on developing innovative therapies for kidney disease. The company is actively engaged in clinical research and has been making strides in advancing its product pipeline. Recent news includes updates on their ongoing studies and regulatory filings that highlight their commitment to addressing unmet medical needs in the renal health sector. Investors can find relevant events and market context that may impact the company's performance on this page.

Research Xortx Therapeutics, Inc.

Alternate listings